OPUS GENETICS INC

IRD · NASDAQ

Updated at 2026-10-15 04:54:16

$4.10-3.3%
Today's High
$4.39
Today’s Low
$4.08
OPUS GENETICS INC (IRD) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$4.39
Previous Close
$4.10
Volume
1.19M
Market Cap
$386.02M
P/E Ratio
--
EPS
$-1.29

Previous Day Range

$4.08$4.39

52-Week Range

$1.70$7.07

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
8 DAVIS DRIVE, DURHAM, NC, UNITED STATES, 27713
Country
US
Listing Date
2004-11-30
Fiscal Year End
December
Shares Outstanding
82.57M
CIK
0001228627

Opus Genetics, Inc. (IRD) is a pioneering biotechnology company dedicated to advancing gene therapies for rare retinal diseases that affect vision. Utilizing cutting-edge gene-editing techniques and a strong research framework, Opus Genetics seeks to address significant unmet medical needs in ocular health. The company's innovative pipeline, bolstered by ongoing clinical trials and strategic partnerships, positions it favorably within the dynamic healthcare sector, offering substantial growth potential for institutional investors.

Financial Metrics

Revenue

2026-06-30

$755K

2026-03-31

$2.15M

2025-12-31

$3.86M

2025-09-30

$3.07M

Operating Expenses

2026-06-30

$17.23M

2026-03-31

$16.5M

2025-12-31

$15.31M

2025-09-30

$11.39M

Net Income

2026-06-30

-$8.09M

2026-03-31

-$65.53M

2025-12-31

-$16.52M

2025-09-30

-$17.45M

Net Profit Margin

2026-06-30

-1.07K%

2026-03-31

-3.03K%

2025-12-31

-427.5%

2025-09-30

-566.87%

Earnings Per Share

2026-06-30

$-0.14

2026-03-31

$-0.75

2025-12-31

$-0.21

2025-09-30

$-0.25

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$7.55M

2026-03-31

-$64.87M

2025-12-31

-$15.11M

2025-09-30

-$17.37M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.